Moors & Cabot’s Merck MRK Stock Holding History

Moors & Cabot’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-800	Closed	-$4K	–	882
2022 Q1	$4K	Buy	+800	New	+$63.1K	﹤0.01%	868
2021 Q4	–	Sell	-2,500	Closed	-$2K	–	946
2021 Q3	$2K	Buy	+2,500	New	+$190K	﹤0.01%	853
2020 Q4	–	Sell	-210	Closed	-$1K	–	762
2020 Q3	$1K	Buy	+210	New	+$16.4K	﹤0.01%	707
2019 Q4	–	Sell	-36,680	Closed	-$29K	–	673
2019 Q3	$29K	Buy	+36,680	New	+$2.94M	﹤0.01%	634
2015 Q2	–	Sell	-1,048	Closed	-$4K	–	538
2015 Q1	$4K	Buy	+1,048	New	+$59.3K	﹤0.01%	514

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Moors & Cabot's MRK Position: Q1 2026 in Review

Moors & Cabot reduced its Merck (MRK) stake by 1.9% in Q1 2026, selling an estimated $219K and leaving 96,078 shares worth $11.6M. The position accounts for 0.49% of the portfolio, ranked #43.

Moors & Cabot first reported a position in MRK in Q1 2014 and has held it in 49 quarters since. The position peaked at $19M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Moors & Cabot held 96,078 shares of Merck worth $11.6M as of Q1 2026.
Moors & Cabot sold 1,894 Merck shares in Q1 2026, an estimated $219K.
Merck made up 0.49% of Moors & Cabot's portfolio in Q1 2026, its #43 holding.
Moors & Cabot first reported a position in Merck in Q1 2014 and has held it in 49 quarters since.
Moors & Cabot's Merck position peaked at $19M in Q1 2024.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.